Don't miss this opportunity to explore the intriguing world of computer-guided drug design as we compare two innovative methodologies: fragment-based drug design and full molecule-based drug design. Our esteemed panelists will delve into these two approaches' strengths, limitations, and future prospects while uncovering potential synergies. Drug design trends in the age of AI
Thursday, September 14 at 8:00 am PT, 11:00 am ET, 16:00 BST Reserve your seat now! |
